Elevance Health Inc.ANTMNYSE

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 79% recommend buying.

Consensus Rating

Buy

34 analysts·High coverage

79%

Rating Distribution

Strong Buy

00%

Buy

2779%

Hold

721%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 10% higher.

Bear Case

$335.00

-31%

Consensus

$529.05

+10%

Bull Case

$625.00

+30%

Price Range34 analysts

Low

Consensus

High

$335.00

$625.00

Current Target

Current Price

$482.58

Upside to Target

$46.47

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Unable to load analyst estimates

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+2.2%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jul 25, 2022Morgan Stanley

Morgan Stanley Maintains Equal-Weight on Elevance Health, Lowers Price Target to $485

Target:$485.00

+0.5%from $482.58

Jun 16, 2022Loop Capital Markets

Loop Capital starts Anthem with Buy, sees sector discount shrinking

Target:$550.00

+20.9%from $454.76

May 25, 2022Wells Fargo

Anthem (ANTM) Stock: $580 Price Target And Overweight Rating

Target:$580.00

+15.6%from $501.53

Apr 25, 2022BMO Capital

BMO Capital Maintains Outperform on Anthem, Raises Price Target to $625

Target:$625.00

+26.1%from $495.61

Apr 22, 2022Deutsche Bank

Deutsche Bank Maintains Buy on Anthem, Raises Price Target to $574

Target:$574.00

+12.5%from $510.40

Apr 21, 2022Morgan Stanley

Morgan Stanley Maintains Overweight on Anthem, Raises Price Target to $607

Target:$607.00

+14.9%from $528.45

Apr 21, 2022Goldman Sachs

Goldman Sachs Maintains Buy on Anthem, Raises Price Target to $605

Target:$605.00

+14.2%from $529.84

Apr 21, 2022Leerink Partners

SVB Leerink Maintains Market Perform on Anthem, Raises Price Target to $555

Target:$555.00

+4.7%from $529.84

Apr 21, 2022Credit Suisse

Anthem (ANTM) PT Raised to $584 at Credit Suisse

Target:$584.00

+11.7%from $522.87

Apr 21, 2022RBC Capital

Anthem (ANTM) PT Raised to $544 at RBC Capital

Target:$544.00

+4.0%from $522.87

Apr 20, 2022Mizuho Securities

Anthem (ANTM) Receives a Buy from Mizuho Securities

Target:$510.00

-3.7%from $529.84

Apr 20, 2022Jefferies

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Anthem (NYSE: ANTM)

Target:$625.00

+18.0%from $529.84

Apr 20, 2022Evercore ISI

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Anthem (ANTM)

Target:$335.00

-36.8%from $529.84

Apr 11, 2022Truist Financial

Anthem (ANTM) Stock: $590 Price Target And Buy Rating

Target:$590.00

+15.5%from $510.64

Apr 4, 2022UBS

Anthem, Inc. (ANTM) Stock: $541 Price Target And Buy Rating

Target:$541.00

+10.6%from $489.34

Jan 27, 2022RBC Capital

Analysts Offer Insights on Healthcare Companies: Anthem (NYSE: ANTM) and Abbott Labs (NYSE: ABT)

Target:$452.00

+4.0%from $434.61

Jan 27, 2022J.P. Morgan

J.P. Morgan Believes Anthem (NYSE: ANTM) Still Has Room to Grow

Target:$500.00

+15.0%from $434.61

Jan 27, 2022BMO Capital

Anthem (ANTM) PT Raised to $510 at BMO Capital

Target:$510.00

+17.3%from $434.61

Jan 26, 2022Evercore ISI

Analysts Offer Insights on Healthcare Companies: Theravance Biopharma (NASDAQ: TBPH) and Anthem (NYSE: ANTM)

Target:$335.00

-21.6%from $427.24

Jan 26, 2022Seaport Global

Anthem (ANTM) PT Raised to $480 at Seaport Global Securities, Following Earnings

Target:$480.00

+12.3%from $427.24

Jan 11, 2022Bernstein

Anthem price target raised to $574 from $559 at Bernstein

Target:$574.00

+26.9%from $452.46

Jan 6, 2022Wells Fargo

Wells Fargo Maintains Their Buy Rating on Anthem (ANTM)

Target:$523.00

+19.3%from $438.22

Dec 14, 2021Goldman Sachs

Anthem initiated with a Conviction Buy at Goldman Sachs

Target:$517.00

+19.5%from $432.72

Nov 30, 2021Wolfe Research

Anthem (ANTM) PT Raised to $433 at Wolfe Research

Target:$433.00

+7.2%from $403.96

Oct 21, 2021Credit Suisse

Anthem (ANTM) PT Raised to $486 at Credit Suisse

Target:$486.00

+13.6%from $428.00

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance